Breaking

treatment

Federal Funding Boosts Behavioral Health, Crisis Services Nationwide
Fitness Shifts

Federal Funding Boosts Behavioral Health, Crisis Services Nationwide

Federal funding of $383.4 million enhances behavioral health services nationwide, focusing on treatment, prevention, and crisis response.

Persephone Blackwood · September 30, 2026
Axogen Acquires BioCircuit Technologies in $200M Deal
Personal Health

Axogen Acquires BioCircuit Technologies in $200M Deal

Axogen acquires BioCircuit Technologies in a $200M deal to expand its peripheral nerve repair offerings and market position.

Persephone Blackwood · September 11, 2026
New Treatment Improves Survival in First-Line Small Cell Lung Cancer
Gut Health

New Treatment Improves Survival in First-Line Small Cell Lung Cancer

New treatment improves survival in first-line small cell lung cancer with a combination of tarlatamab and durvalumab, showing a significant clinical benefit.

Ottoline Dunmore · September 9, 2026
Hospitals struggle with high costs of CAR T-cell therapy programs
Gut Health

Hospitals struggle with high costs of CAR T-cell therapy programs

Hospitals face steep CAR T-cell therapy costs, from drug pricing to staffing and safety protocols, straining smaller clinics and outpatient programs.

Ottoline Dunmore · September 8, 2026
Tozorakimab Reduces COPD Inflammation Across Multiple Pathways
Fitness Shifts

Tozorakimab Reduces COPD Inflammation Across Multiple Pathways

tozorakimab COPD therapy shows significant reduction of inflammation by targeting multiple pathways, offering new hope beyond eosinophil‑focused treatments.

Seraphina Wentworth · September 7, 2026
Vestbo says eosinophil-guided steroid cut safe
Personal Health

Vestbo says eosinophil-guided steroid cut safe

Eosinophil guided steroid reduction in COPD cuts ICS doses without raising severe flare‑ups, according to the COPERNICOS trial at the 2026 ERS…

Persephone Blackwood · September 6, 2026
FDA approves Camizestrant for breast cancer with ESR1 mutations
Gut Health

FDA approves Camizestrant for breast cancer with ESR1 mutations

The FDA approves camizestrant for ER-positive, HER2-negative metastatic breast cancer with ESR1 mutations. Learn about this new treatment option and its clinica

Seraphina Wentworth · September 5, 2026
Adjunct Antipsychotics Offer Hope for Depression Treatment
Mind Body

Adjunct Antipsychotics Offer Hope for Depression Treatment

Adjunct antipsychotics are emerging as a promising option for treating depression when antidepressants fall short, offering new hope for patients.

Seraphina Wentworth · September 4, 2026
Mountain West Cancer Care Hampered by Distance, Telehealth
Personal Health

Mountain West Cancer Care Hampered by Distance, Telehealth

Cancer telehealth is bridging the vast distance barrier for Mountain West patients, offering remote specialist access and reducing travel hardships.

Seraphina Wentworth · September 2, 2026
New Drug Reduces Heart Attack Risk
Habit Logs

New Drug Reduces Heart Attack Risk

Evolocumab reduces heart attack risk by 20% in high-risk patients with atherosclerosis or diabetes, lowering mortality rates effectively.

Seraphina Wentworth · September 1, 2026